Incidence, Pathophysiology, and Impact of Coronavirus Disease 2019 (COVID-19) on Acute Ischemic Stroke
Document Type
Article
Medical Subject Headings
Angiotensin-Converting Enzyme 2; Antibodies, Antiphospholipid (metabolism); Arrhythmias, Cardiac (physiopathology); Betacoronavirus; Brain Ischemia (epidemiology, metabolism, physiopathology, surgery); COVID-19; Conscious Sedation; Coronavirus Infections (epidemiology, metabolism, physiopathology); Endothelium (physiopathology); Fibrin Fibrinogen Degradation Products (metabolism); Humans; Intubation, Intratracheal (methods); Myocardium (metabolism); Pandemics; Peptidyl-Dipeptidase A (metabolism); Pneumonia, Viral (epidemiology, metabolism, physiopathology); Practice Guidelines as Topic; SARS-CoV-2; Stroke (epidemiology, metabolism, physiopathology, surgery); Thrombectomy (methods); Thrombophilia (metabolism, physiopathology)
Publication Date
10-1-2020
Publication Title
World neurosurgery
E-ISSN
1878-8769
Volume
142
First Page
523
Last Page
525
PubMed ID
32987584
Digital Object Identifier (DOI)
10.1016/j.wneu.2020.07.158
Recommended Citation
Majmundar, Neil; Ducruet, Andrew; Prakash, Tannavi; Nanda, Anil; and Khandelwal, Priyank, "Incidence, Pathophysiology, and Impact of Coronavirus Disease 2019 (COVID-19) on Acute Ischemic Stroke" (2020). Neurosurgery. 2205.
https://scholar.barrowneuro.org/neurosurgery/2205